Prospective Clinical Evaluation of High-Purity Type I Collagen in Select High-Risk Hernia Repair Scenarios

This prospective, single-arm clinical study evaluates the safety, feasibility, and early clinical outcomes of High-Purity Type I Collagen (HPTC; Surgicoll-Mesh®) when used as a biologic reinforcement in selected hernia repair scenarios where permanent synthetic mesh placement is undesirable. Outcomes focus on early postoperative safety, wound healing, and complication profiles over an 8-week follow-up period.

NCT Number	NCT07360691
Lead Sponsor	Adichunchanagiri Institute of Medical Sciences, B G Nagara
Conditions	Hernia, Ventral Hernia, Incisional Hernia, İnguinal Hernia, Abdominal Wall Hernia, Surgical Site Infection, Postoperative Complications
Enrollment	30 participants
Start Date	2026-01-05
Primary Completion	2026-03-08 (estimated)
Study Completion	2026-03-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-23